Christina Zielinski always wanted to become a doctor, but then research got hold of her, or, more precisely, human T cells did. Christina Zielinski has been focusing on these major players in the
DZIF scientists from the University of Bonn have shown that not all conventional Zika virus molecular diagnostic tests are sufficiently reliable. They developed optimised assays and a control for
In a treatment centre in Guinea, DZIF researchers from the Heinrich Pette Institute (HPI) and the Bernhard Nocht Institute (BNITM) have, for the first time, identified the human immune response in
The clinical phase I trial of a potential vaccine against the dreaded Ebola virus has been successfully completed at four partner sites in Africa and Europe. The safety of the tested vaccine “rVSV
An international research group has identified a cellular factor of the human cell that is indispensable to the replication of Human Immunodeficiency Virus (HIV-1). Scientists of the Paul-Ehrlich
World Tuberculosis Day on 24 March is a reminder to the public that 1.5 people still die of tuberculosis (TB) every year. The rise of multidrug-resistant strains is particularly problematic, currently
Many viral diseases tend to become chronic - including infections with the HI virus. Scientists from the DZIF site Bonn-Köln and from the TU München have now identified an immune factor which is
Infections with Zika viruses are usually harmless. However, in Brazil, reports about a potential link between an infection with the virus and brain malformations (microcephaly) in newborns have
Researchers at the Heinrich Pette Institute, Hamburg, and at the Dresden Technical University (TUD) succeeded in developing a designer enzyme that is capable of specifically removing the provirus from
Scientists led by the Leibniz Research Center Borstel, the Institute of Microbiology and Laboratory Diagnostics in Gauting, the Institute of Medical Microbiology of the University of Zurich and the
